The DISCO-MS trial looked at the question “Can we define a population of patients in whom it’s safe to discontinue their disease modifying therapy (DMT) for MS as they age?”…
Read More
Dr. Timothy Vollmer hosts an informal discussion of the state of MS research today. Recorded on May 19, 2022. Dr. Vollmer talks about remyelination prospects, treatments for progressive MS, neurofilament…
One of the problems faced by some people with multiple sclerosis who are working is the need for frequent absences. The increased need for absences among people with MS is…
An Interview with Christy Dittmar, MS, OTR/L, CDRS. As we’ve discussed throughout this issue, fatigue is an extremely common, complex, and challenging problem in MS. Frustratingly, there is no one…
Fatigue is not only one of the most common MS symptoms, it’s also one of the most frustrating for people to manage. In this issue, we’re presenting an update to…
The Rocky Mountain MS Center’s 2022 Spring Education Summit was held Saturday, April 30, 2022, in-person at the Anschutz Medical Campus in Aurora, Colorado, and livestreaming on Zoom. Below is…
NOTE: This information has been adapted from previous updates and is current as of April 11, 2022. Below are answers to some of the frequently asked questions we’ve received recently…
MS Awareness Month is a chance to bring multiple sclerosis to the forefront, to help advocate for people and families living with MS every day, and to educate the public….
MS Awareness Month is a chance to bring multiple sclerosis to the forefront, to help advocate for people and families living with MS every day, and to educate the public….
Jane was diagnosed with multiple sclerosis twelve years ago at the age of 64. “First I experienced numbness in my feet and then it progressed to my leg. After seeing…